Summary
Cogentix Medical Inc (Cogentix Medical), formerly Vision-Sciences, Inc. is a medical device company that offers patient care products. The company offers PrimeSight, macroplastique, urgent PC and PTQ products. Its products are used in urology, bariatric medicine, critical care, faecal incontinence, gastroenterology, gynecology, infection prevention, otolaryngology and pulmonology specialties. The company’s products provide treatment of stress urinary incontinences, overactive bladder, faecal incontinence, vesicoureteral reflux, stress urinary incontinence, and overactive bladders. It sells its products through a network of distributors in the US and abroad. Cogentix Medical is headquartered in Minnetonka, Minnesota, the US.
Cogentix Medical Inc (CGNT) - Medical Equipment - Deals and Alliances Profile provides you comprehensive data and trend analysis of the company's Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.
GlobalData derived the data presented in this report from proprietary in-house Medical eTrack deals database, and primary and secondary research.
Scope
- Financial Deals - Analysis of the company's financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year - Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type - Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region - Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector - Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals - Information on the company's major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description - A brief description of the company's operations.
- Key Employees - A list of the key executives of the company.
- Important Locations and Subsidiaries - A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors - A list of the key competitors of the company.
- Key Recent Developments - A brief on recent news about the company.
Reasons to Buy
Get detailed information on the company's financial deals that enable you to understand the company's expansion/divestiture and fund requirements
- The profile enables you to analyze the company's financial deals by region, by year, by business segments and by type, for a five year period.
Understand the company's business segments' expansion / divestiture strategy
- The profile presents deals from the company's core business segments' perspective to help you understand its corporate strategy.
Access elaborate information on the company's recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company's key financial metrics and ratios.
Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company's business structure, locations and subsidiaries, key executives and key competitors.
Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.
Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.
Note*: Some sections may be missing if data is unavailable for the company.
'
Table of Contents
Table of Contents 2
List of Tables 3
List of Figures 4
Cogentix Medical Inc, Medical Equipment, Deals By Year, 2011 to YTD 2017 5
Cogentix Medical Inc, Medical Equipment Deals By Type, 2011 to YTD 2017 6
Cogentix Medical Inc, Medical Equipment, Deals By Region, 2011 to YTD 2017 7
Cogentix Medical Inc, Medical Equipment, Deals By Market, 2011 to YTD 2017 8
Cogentix Medical Inc, Medical Equipment, Deals Summary, 2011 to YTD 2017 9
Cogentix Medical Inc, Medical Equipment, Deal Details 10
Merger 10
Uroplasty and Vision-Sciences Merge 10
Equity Offering 11
Cogentix Medical to Raise USD25 Million in Share Purchase Plan 11
Vision-Sciences Announces Private Placement Of Shares For Up To US$21 Million 12
Vision-Sciences Files Registration Statement For Public Offering Of Securities To Raise Up To US$25 Million 13
Vision-Sciences Completes Private Placement Of US$10.5 Million 14
Cogentix Medical Inc - Key Competitors 16
Key Employees 17
Locations And Subsidiaries 18
Head Office 18
Other Locations & Subsidiaries 18
Recent Developments 19
Financial Announcements 19
Mar 09, 2017: Cogentix Medical Reports Strong Fourth Quarter Operating Results 19
Nov 08, 2016: Cogentix Medical Reports 13 Percent Q3 Revenue Growth 21
Aug 02, 2016: Cogentix Medical Reports 17 Percent Q2 Revenue Growth 23
May 05, 2016: Cogentix Medical Achieves Second Consecutive Quarter of Cash Operating Profit; Reports 74% Revenue Growth for the Quarter Ended March 31, 2016 25
Mar 03, 2016: Cogentix Medical Reports 104% Revenue Growth for the Quarter Ended December 31; Achieves Cash Operating Profit Milestone 26
Feb 02, 2016: Cogentix Medical Announces Preliminary Resultsfor the Quarter Ended December 31 28
Corporate Communications 29
Jul 12, 2016: Darin Hammers Appointed President And CEO Of Cogentix Medical 29
Jun 22, 2016: Healthcare Industry Leader Kenneth A. Samet Joins Cogentix Medical Board of Directors 30
Jun 15, 2016: Brett Reynolds Rejoins Cogentix Medical As Chief Financial Officer 31
Appendix 32
Methodology 32
About GlobalData 32
Contact Us 32
Disclaimer 32
List of Tables
Cogentix Medical Inc, Medical Equipment, Key Facts, 2015 1
Cogentix Medical Inc, Medical Equipment, Deals Summary, 2011 to YTD 2017 1
Cogentix Medical Inc, Medical Equipment, Deals By Year, 2011 to YTD 2017 5
Cogentix Medical Inc, Medical Equipment Deals By Type, 2011 to YTD 2017 6
Cogentix Medical Inc, Medical Equipment, Deals By Region, 2011 to YTD 2017 7
Cogentix Medical Inc, Deals By Market, 2011 to YTD 2017 8
Cogentix Medical Inc, Medical Equipment, Deals Summary, 2011 to YTD 2017 9
Uroplasty and Vision-Sciences Merge 10
Cogentix Medical to Raise USD25 Million in Share Purchase Plan 11
Vision-Sciences Announces Private Placement Of Shares For Up To US$21 Million 12
Vision-Sciences Files Registration Statement For Public Offering Of Securities To Raise Up To US$25 Million 13
Vision-Sciences Completes Private Placement Of US$10.5 Million 14
Cogentix Medical Inc, Key Competitors 16
Cogentix Medical Inc, Key Employees 17
Cogentix Medical Inc, Subsidiaries 18
List of Figures
Cogentix Medical Inc, Medical Equipment, Deals by Type, 2011 to YTD 2017 1
Cogentix Medical Inc, Medical Equipment, Deals By Year, 2011 to YTD 2017 1
Cogentix Medical Inc, Medical Equipment, Deals By Region, 2011 to YTD 2017 1
Cogentix Medical Inc, Medical Equipment, Deals By Market, 2011 to YTD 2017 1
Cogentix Medical Inc, Medical Equipment, Deals By Year, 2011 to YTD 2017 5
Cogentix Medical Inc, Medical Equipment, Deals by Type, 2011 to YTD 2017 6
Cogentix Medical Inc, Medical Equipment, Deals By Region, 2011 to YTD 2017 7
Cogentix Medical Inc, Medical Equipment, Deals by Market, 2011 to YTD 2017 8